Salarius Pharmaceuticals's total assets for Q2 2025 were $1.39M, a decrease of -40.46% from the previous quarter. SLRX total liabilities were $2.22M for the fiscal quarter, a -2.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.